Amphera B.V.
Research - 's-Hertogenbosch, North Brabant, Netherlands
Amphera B.V. Employees
Amphera B.V. Details
Amphera is an advanced-clinical-stage biotechnology company developing dendritic cell therapies to treat cancer. Amphera's management team has extensive experience of building successful life science companies and creating high-value shareholder exit opportunities. The Company has three ongoing clinical programmes with MesoPher – its personalised immuno-oncology cell therapy, comprised of autologous dendritic cells loaded with PheraLys, its proprietary allogeneic lysate of cancer cell lines.The lead programme is in a pivotal phase II/III study in pleural mesothelioma – a cancer of the lining of the lungs. The second programme is a phase II study in peritoneal mesothelioma – a cancer of the lining of the abdominal cavity. Amphera has obtained FDA and EMA orphan-designation for MesoPher for mesothelioma. The third programme is in a phase II study in pancreatic cancer. Amphera is fully financed to complete its current three clinical development programmes.
Amphera B.V. Technologies
Load Balancers
Nginx
CMS
WordPress.org
Tag Management
Google Tag Manager
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework